NVNereida Valero-Cedeño

Nereida Valero-Cedeño

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nereida Valero-Cedeño has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Possible Effects of C‐Reactive Protein in the Central Nervous System During Venezuelan Equine Encephalitis Virus Infection

    by Nereida Valero‐Cedeño, Anyelo Durán, Jesus A. Mosquera

    Venezuelan equine encephalitis virus (VEEV) is an alphavirus vectored by mosquitos. It can cause disease in equines and humans characterised by a febrile illness that may progress into encephalitis. Replication of VEEV in the central nervous system induces activation of glial cells and neurons, compromising the blood‐brain barrier (BBB) and inducing a state of neuroinflammation. This inflammation can lead to symptoms such as confusion, seizures, and coma, and sustained inflammation contributes to neurodegeneration. C‐reactive protein (CRP) is a biomarker that has previously been associated with inflammation and infection. It is now known that its functions are related to various brain disorders. Circulating increased CRP levels correlate with alterations in brain structure and metabolism associated with cognitive vulnerability, suggesting the effect of CRP on brain cell biology. However, the fact that alphavirus (including VEEV) infection is accompanied by increased CRP production makes it likely that VEEV infection induces the production of this protein systemically and/or mediated by the activation of brain cells. This review highlights a role of CRP in the brain parenchyma, influencing various aspects of VEEV brain infection such as general inflammation, BBB permeability, hypoxia, apoptosis, interaction with different brain cells, and brain metabolism. The influence of CRP in the brain may exacerbate the inflammatory process induced by VEEV. The existence of several drugs with anti‐CRP effects opens their use in the treatment of VEEV brain infection.


  • BACTERIAL TRANSLOCATION: MICROBIOTA-INTESTINE-LUNG AXIS AND PRO-INFLAMMATORY STATUS IN THE SEVERITY OF COVID-19

    by Facultad de Ciencias de la Salud Carrera de Laboratorio Clínico, Nereida Valero-Cedeño, Danna Álava, Ronny Rodríguez, Maricarmen Chacín, Facultad de Ciencias de la Salud Universidad Simón Bolívar, Maritza Cabrera-Hernández, Vicerrectoría de Investigación Y Postgrado Centro de Investigación de Estudios Avanzados del Maule (Cieam), Teresa Véliz-Castro, Yenddy Carrero, et al.

    Although severe acute respiratory syndrome coronavirus – 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19) pandemic, is primarily associated with a respiratory infection, it has also been linked to multisystem involvement that includes the digestive tract. Gastrointestinal (GI) manifestations are common in patients with COVID-19 due to the high viral load lodged in the small intestine's mucosa. As a result, it causes an increase in the permeability of the intestinal barrier that favours the passage and translocation of bacteria, from the lumen of the intestine, towards the internal environment, with the appearance of sepsis, with evidence that SARS-CoV-2 has been found in faeces. This article highlights epidemiology, clinical symptoms, and mechanisms related to manifestations of disease in the GI tract and its pathogenesis in patients with COVID-19. It highlights bacterial translocation and COVID-19, mechanisms that control bacterial translocation, intestinal infection and feco-oral transmission, defense